PIPERAZINE CITRATE Drug Patent Profile
✉ Email this page to a colleague
When do Piperazine Citrate patents expire, and when can generic versions of Piperazine Citrate launch?
Piperazine Citrate is a drug marketed by Alpharma Us Pharms, Lannett, Luitpold, and Impax Labs. and is included in four NDAs.
The generic ingredient in PIPERAZINE CITRATE is piperazine citrate. There are eighteen drug master file entries for this compound. Additional details are available on the piperazine citrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PIPERAZINE CITRATE?
- What are the global sales for PIPERAZINE CITRATE?
- What is Average Wholesale Price for PIPERAZINE CITRATE?
Summary for PIPERAZINE CITRATE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 54 |
| Patent Applications: | 4 |
| DailyMed Link: | PIPERAZINE CITRATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PIPERAZINE CITRATE
US Patents and Regulatory Information for PIPERAZINE CITRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alpharma Us Pharms | PIPERAZINE CITRATE | piperazine citrate | SYRUP;ORAL | 080774-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Impax Labs | PIPERAZINE CITRATE | piperazine citrate | TABLET;ORAL | 080874-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lannett | PIPERAZINE CITRATE | piperazine citrate | SYRUP;ORAL | 080963-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Luitpold | PIPERAZINE CITRATE | piperazine citrate | SYRUP;ORAL | 080671-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
